Newsroom | Novartis Review recent and past Novartis healthcare news stories, including media releases and featured information
Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug . . . Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3 The layoffs affect Swiss manufacturing facilities Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s amycretin helps regulate blood sugar
Novartis News | Latest News - NewsNow Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news
Novartis scores FDA approval for new version of SMA gene therapy Novartis has received an FDA approval for Itvisma, a new version of the company’s gene therapy Zolgensma, to treat older patients with spinal muscular atrophy (SMA) The approval comes more than